TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34206642

Group type: EXPERIMENTAL
Intervention: MCT meal (Ketonformula®)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo meal
Number of subjects: 20
Study: 33171566

Group type: COMPARATOR
Intervention: Free hand group
Number of subjects: 18

Group type: COMPARATOR
Intervention: 1 mm group
Number of subjects: 18

Group type: COMPARATOR
Intervention: 2 mm group
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 14 mm group
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 3 mm group
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 5 mm group
Number of subjects: 18
Study: 33722805

Group type: COMPARATOR
Intervention: 18 mm balloon dilatation (Group DIL)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 20 mm diameter, partially covered Hanarostent NCN (Group STENT)
Number of subjects: 13
Study: 32946885

Group type: EXPERIMENTAL
Intervention: eMULTIPAP course
Number of subjects: 0
Study: 33749823

Group type: EXPERIMENTAL
Intervention: Intervention to improve maternal reminiscing
Number of subjects: 242
Study: 32271183

Group type: EXPERIMENTAL
Intervention: FDC IBU/APAP 250/500 mg
Number of subjects: 691

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 691

Group type: COMPARATOR
Intervention: IBU 250 mg
Number of subjects: 691

Group type: COMPARATOR
Intervention: APAP 650 mg
Number of subjects: 691
Study: 35965962

Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion combined with crystalloid coload
Number of subjects: 200

Group type: COMPARATOR
Intervention: Norepinephrine infusion combined with colloid coload
Number of subjects: 200
Study: 32858429

Group type: EXPERIMENTAL
Intervention: Body armor
Number of subjects: 12

Group type: COMPARATOR
Intervention: No body armor
Number of subjects: 12
Study: 36367633

Group type: EXPERIMENTAL
Intervention: SC-PIES (social cognitive theory-based pre-implementation enhancement strategy)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Active control (administrative meeting)
Number of subjects: 43
Study: 33482135

Group type: EXPERIMENTAL
Intervention: Ningmitai capsule (NMT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 32157418

Group type: EXPERIMENTAL
Intervention: Myelofibrosis
Number of subjects: 2750

Group type: COMPARATOR
Intervention: Control (without myelofibrosis)
Number of subjects: 2750

Group type: EXPERIMENTAL
Intervention: Ruxolitinib treatment
Number of subjects: 2750
Study: 36403273

Group type: EXPERIMENTAL
Intervention: Long-term nursing intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 60
Study: 33713057

Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen at 10mg/kg/dose 8 hourly
Number of subjects: 104

Group type: COMPARATOR
Intervention: Intravenous diclofenac sodium at 1mg/kg/dose 8 hourly
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen
Number of subjects: 104

Group type: COMPARATOR
Intervention: Intravenous diclofenac sodium
Number of subjects: 104
Study: 34973966

Group type: EXPERIMENTAL
Intervention: IDEA (intelligent detection endoscopic assistant)
Number of subjects: 17787
Study: 32683359

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 349

Group type: COMPARATOR
Intervention: Standard antibiotics (penicillin or ampicillin)
Number of subjects: 349
Study: 35855841

Group type: EXPERIMENTAL
Intervention: TWG tablets + acitretin capsules (Group A)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Compound glycyrrhizin capsules + acitretin capsules (Group B)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Acitretin capsules (Group C)
Number of subjects: 36
Study: 35279215

Group type: EXPERIMENTAL
Intervention: AMETHIST intervention (Adapted Microplanning to Eliminate Transmission of HIV in Sex Transactions) plus the Sisters programme (usual care)
Number of subjects: 4400

Group type: COMPARATOR
Intervention: Sisters programme (usual care)
Number of subjects: 4400
Study: 33846219

Group type: EXPERIMENTAL
Intervention: Rituximab treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 36470077

Group type: EXPERIMENTAL
Intervention: SCTV01C 20 μg
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: SCTV01C 40 μg
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study: 33635568

Group type: EXPERIMENTAL
Intervention: High-risk alcohol drinking
Number of subjects: 8403

Group type: EXPERIMENTAL
Intervention: Highest blood cadmium quartile
Number of subjects: 8403

Group type: EXPERIMENTAL
Intervention: High-risk drinking and blood cadmium levels
Number of subjects: 8403
Study: 32199723

Group type: COMPARATOR
Intervention: Control group (bundled recommendation video)
Number of subjects: 762

Group type: EXPERIMENTAL
Intervention: Top concern group (control + video addressing the top HPV vaccine concern)
Number of subjects: 762

Group type: EXPERIMENTAL
Intervention: All-concerns group (control + ≥1 videos addressing all concerns)
Number of subjects: 762
Study: 35500460

Group type: EXPERIMENTAL
Intervention: Durvalumab with concurrent chemoradiotherapy (CCRT) including etoposide and cisplatin, 4 cycles every 3 weeks, followed by durvalumab consolidation therapy every 4 weeks for up to 2 years.
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Durvalumab with CCRT
Number of subjects: 51

Group type: COMPARATOR
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 51
Study: 33395189

Group type: EXPERIMENTAL
Intervention: Randomization test of robustness applied to neural modules of the pharynx
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-neuron loss
Number of subjects: 0
Study: 35564343

Group type: EXPERIMENTAL
Intervention: Promotion focus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prevention focus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gain-oriented message framing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Avoidance-oriented message framing
Number of subjects: 0
Study: 33819615

Group type: EXPERIMENTAL
Intervention: ICS withdrawal group (IWG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous ICS group (CIG)
Number of subjects: 0
Study: 34744048

Group type: EXPERIMENTAL
Intervention: CuN-DBS
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: PPN-DBS
Number of subjects: 6

Group type: COMPARATOR
Intervention: sham-DBS
Number of subjects: 6
Study: 34519140

Group type: EXPERIMENTAL
Intervention: Blended learning
Number of subjects: 101

Group type: COMPARATOR
Intervention: Face‐to‐face learning
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Both training methods
Number of subjects: 101
Study: 36123245

Group type: EXPERIMENTAL
Intervention: Microwave ablation (MWA)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Resection
Number of subjects: 105
Study: 33592841

Group type: EXPERIMENTAL
Intervention: T-MSAT + integrative Korean medicine therapy (IKMT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: IKMT (Control)
Number of subjects: 100
Study: 35440429

Group type: EXPERIMENTAL
Intervention: Nurse practitioner-pharmacist telehealth collaboration
Number of subjects: 30
Study: 32343940

Group type: EXPERIMENTAL
Intervention: Barbed reposition pharyngoplasty (BRP)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Uvulopalatopharyngoplasty (UPPP)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Uvulopalatopharyngoplasty (UPPP) with hyoid suspension (HS)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Barbed reposition pharyngoplasty (BRP) with hyoid suspension (HS)
Number of subjects: 122
Study: 33347474

Group type: EXPERIMENTAL
Intervention: Rotavirus vaccine (RV) and pneumococcal conjugate vaccine (PCV)
Number of subjects: 2635
Study: 34982486

Group type: EXPERIMENTAL
Intervention: 1.8 g/day of EPA/DHA
Number of subjects: 881

Group type: COMPARATOR
Intervention: Corn oil (control)
Number of subjects: 881
Study: 33581283

Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS treatment at the dorsolateral prefrontal cortex (DLPFC) for 30 sessions over six weeks (five days per week) with a three-month follow-up.
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sham treatment group for 30 sessions over six weeks (five days per week) with a three-month follow-up.
Number of subjects: 75
Study: 34323584

Group type: EXPERIMENTAL
Intervention: Model implied instrumental variable, two stage least squares (MIIV‐2SLS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maximum likelihood (ML)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diagonally weighted least squares (DWLS)
Number of subjects: 0
Study: 34127018

Group type: EXPERIMENTAL
Intervention: Patellar eversion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patellar lateral retraction
Number of subjects: 0
Study: 35199592

Group type: EXPERIMENTAL
Intervention: Olive cream
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 103
Study: 34306069

Group type: EXPERIMENTAL
Intervention: Laparoscopic radical cystectomy (LRC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 60
Study: 35301133

Group type: EXPERIMENTAL
Intervention: Aspirin (two common dosages)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Data monitoring committee (DMC) oversight
Number of subjects: 0
Study: 35373017

Group type: EXPERIMENTAL
Intervention: 1.5 mg Dulaglutide (DU) weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin Glargine (IG) daily
Number of subjects: 0
Study: 35627554

Group type: EXPERIMENTAL
Intervention: VR group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CVR group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: OCULUS group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Classic programme group (OTAGO)
Number of subjects: 60
Study: 34682669

Group type: EXPERIMENTAL
Intervention: Corrective Exercise Group (CEG)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Resistance Exercise Group (REG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Physical Therapy Group (PTG)
Number of subjects: 36
Study: 32901323

Group type: EXPERIMENTAL
Intervention: Damage Control Surgery (DCS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional Treatment (Group C)
Number of subjects: 21
Study: 34519843

Group type: EXPERIMENTAL
Intervention: Continence dish
Number of subjects: 100
Study: 32503611

Group type: EXPERIMENTAL
Intervention: Parent-Infant-Psychotherapy (PIP)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 180
Study: 32907591

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg body mass)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 34748376

Group type: EXPERIMENTAL
Intervention: Flexible Sigmoidoscopy (FS) screening
Number of subjects: 34272

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 34272
Study: 34879448

Group type: EXPERIMENTAL
Intervention: Tapinarof 1% cream once daily for 12 weeks
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Vehicle cream once daily for 12 weeks
Number of subjects: 1025
Study: 34382279

Group type: EXPERIMENTAL
Intervention: Handover education programme based on situated learning theory (lectures, expert observations, role playing, peer learning, reflection)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Lectures and observation of handovers (control group)
Number of subjects: 77
Study: 34531221

Group type: EXPERIMENTAL
Intervention: Endometrial scratch (ES) intervention
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control arm (no ES)
Number of subjects: 27
Study: 35756424

Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic hepatectomy
Number of subjects: 122
Study: 36175551

Group type: EXPERIMENTAL
Intervention: Stressor-exposed groups (psychosocial challenge)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Non-stressor groups (no psychosocial challenge)
Number of subjects: 76
Study: 33880548

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient powder (MNP)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 321
Study: 35582993

Group type: EXPERIMENTAL
Intervention: Exercise group (n=61)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Usual care group (n=60)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 121
Study: 34120852

Group type: EXPERIMENTAL
Intervention: Double-guidewire technique (DGT) with pancreatic plastic stent placement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Double-guidewire technique (DGT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classic ERCP (Control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Precut technique alone
Number of subjects: 0
Study: 32932346

Group type: EXPERIMENTAL
Intervention: Higher positive end-expiratory pressure (PEEP) approach
Number of subjects: 8
Study: 35609351

Group type: EXPERIMENTAL
Intervention: GnRH-antagonist protocol
Number of subjects: 940

Group type: COMPARATOR
Intervention: GnRH-agonist protocol
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: PF on the day of OPU
Number of subjects: 940
Study: 33888576

Group type: EXPERIMENTAL
Intervention: Active device (AD)
Number of subjects: 128

Group type: COMPARATOR
Intervention: General recommendations (GR)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Inactive device (ID)
Number of subjects: 128
Study: 35357350

Group type: EXPERIMENTAL
Intervention: Routine drug treatment
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Increased anti-infective treatment
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 68
Study: 33524970

Group type: EXPERIMENTAL
Intervention: Silodosin 4 mg once daily
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once daily
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study: 32016387

Group type: EXPERIMENTAL
Intervention: FCHQ (irinotecan, 5-fluorouracil, leucovorin with high quality CT)
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: FCSD (irinotecan, 5-fluorouracil, leucovorin with standard quality CT)
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: FHQ (irinotecan, 5-fluorouracil, leucovorin with high quality CT)
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: FSD (irinotecan, 5-fluorouracil, leucovorin with standard quality CT)
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Cetuximab-containing sets (FCHQ and FCSD)
Number of subjects: 667
Study: 36123597

Group type: EXPERIMENTAL
Intervention: Implementation program (thematic quality circles, e‐learning, basic expenditure reimbursements, additional bonus payments, computerized decision support system)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Performance-based additional bonus payment
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: E-learning participation
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Expenditure reimbursement
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Participants' views on implementation
Number of subjects: 312
Study: 34087659

Group type: EXPERIMENTAL
Intervention: 80% oxygen throughout surgery and for the first two postoperative hours
Number of subjects: 260

Group type: COMPARATOR
Intervention: 30% oxygen throughout surgery and for the first two postoperative hours
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: 80% oxygen
Number of subjects: 260

Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 260
Study: 32428523

Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride (SDF) solution
Number of subjects: 302

Group type: COMPARATOR
Intervention: 5% sodium fluoride (NaF) varnish
Number of subjects: 302
Study: 36352742

Group type: EXPERIMENTAL
Intervention: Fermented rapeseed meal (FRSM)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Rapeseed meal (RSM)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Rapeseed meal (RSM) or Fermented rapeseed meal (FRSM) at 100%
Number of subjects: 140

Group type: COMPARATOR
Intervention: All experimental treatments (including RSM and FRSM)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Increasing levels of RSM or FRSM
Number of subjects: 140
Study: 33383536

Group type: EXPERIMENTAL
Intervention: GJH group (Beighton score ≥ 4)
Number of subjects: 489
Study: 35282567

Group type: EXPERIMENTAL
Intervention: Gutta-percha
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate (MTA) and gutta-percha
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gutta-percha and glass-fiber posts
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MTA and glass-fiber posts
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (prefilling scan)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Wide 80∗50 mm FOV
Number of subjects: 20
Study: 33433820

Group type: EXPERIMENTAL
Intervention: Combined classroom/parental intervention
Number of subjects: 5029

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 5029
Study: 32865857

Group type: EXPERIMENTAL
Intervention: Biopsychosocial functional activity program (12-month intervention with a 6-week teaching program followed by home follow-up)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35324507

Group type: EXPERIMENTAL
Intervention: DTxP (digital therapeutics, virtual reality, psychological intervention for pain)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: DTxP
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham placebo
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 42
Study: 33165251

Group type: EXPERIMENTAL
Intervention: Parent-focused literacy intervention (Reach Out and Read)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Baseline measurements (preintervention)
Number of subjects: 38
Study: 34826022

Group type: EXPERIMENTAL
Intervention: 1927 nm thulium laser (FTL)
Number of subjects: 27

Group type: COMPARATOR
Intervention: 2940 nm Er:YAG laser (FEL)
Number of subjects: 27
Study: 33993685

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 patients
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 patients with interstitial pneumonia
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 patients without interstitial pneumonia
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 patients with mild COVID-19
Number of subjects: 187

Group type: COMPARATOR
Intervention: Blood donors
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 patients with active EBV infection markers
Number of subjects: 187
Study: 32363634

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 736

Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 736
Study: 34605016

Group type: EXPERIMENTAL
Intervention: Suction Tube Uterine Tamponade (STUT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Routine Uterine Balloon Tamponade (UBT)
Number of subjects: 24
Study: 32435860

Group type: EXPERIMENTAL
Intervention: Module-based training for nurses
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 68
Study: 34482594

Group type: EXPERIMENTAL
Intervention: EBP mentor development programs
Number of subjects: 15
Study: 33056960

Group type: EXPERIMENTAL
Intervention: Femto‐DSEK
Number of subjects: 37

Group type: COMPARATOR
Intervention: DSAEK
Number of subjects: 37
Study: 35157830

Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg orally twice daily)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control (enzalutamide 160 mg orally once daily or abiraterone 1000 mg orally once daily plus prednisone 5 mg orally twice daily)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control (enzalutamide or abiraterone)
Number of subjects: 245
Study: 34987314

Group type: EXPERIMENTAL
Intervention: MAVIG X-ray protective drape (MXPD)
Number of subjects: 60
Study: 36360996

Group type: EXPERIMENTAL
Intervention: TaU + MIND (treatment as usual plus mindfulness-based therapy)
Number of subjects: 177

Group type: COMPARATOR
Intervention: TaU (treatment as usual)
Number of subjects: 177
Study: 33081717

Group type: EXPERIMENTAL
Intervention: HP‐diet and β‐cryptoxanthin
Number of subjects: 92

Group type: COMPARATOR
Intervention: HP‐diet
Number of subjects: 92

Group type: COMPARATOR
Intervention: β‐cryptoxanthin
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control
Number of subjects: 92
Study: 35197097

Group type: EXPERIMENTAL
Intervention: Risk prediction model for pneumonia after AADS
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Training set multivariate analysis
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Calibration of the model
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Discrimination of the model
Number of subjects: 492
Study: 34337667

Group type: EXPERIMENTAL
Intervention: Handgrip strength assessment
Number of subjects: 0
Study: 34541872

Group type: EXPERIMENTAL
Intervention: RG‐TFV rectal gel daily
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: RG‐TFV rectal gel before and after receptive anal intercourse (RAI)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Daily oral FTC/TDF
Number of subjects: 195

Group type: COMPARATOR
Intervention: All three PrEP regimens (RG‐TFV daily, RG‐TFV before and after RAI, and daily oral FTC/TDF)
Number of subjects: 195
Study: 32050782

Group type: EXPERIMENTAL
Intervention: Galcanezumab 300 mg
Number of subjects: 237

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study: 33412602

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention for critical care provision
Number of subjects: 1431

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention
Number of subjects: 1431
Study: 35809658

Group type: EXPERIMENTAL
Intervention: Optic-haptic junction oriented vertically
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Optic-haptic junction oriented horizontally
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Optic-haptic junction oriented superonasally
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Optic-haptic junction oriented inferonasally
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 163
Study: 34284804

Group type: EXPERIMENTAL
Intervention: Elos 2.0 Programme
Number of subjects: 3800

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3800
Study: 34556559

Group type: EXPERIMENTAL
Intervention: Routine chest pressure with direct current cardioversion from the first defibrillation shock.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving four sequential biphasic shocks of 150 J, 200 J, 360 J and 360 J with chest pressure on the last shock.
Number of subjects: 0
Study: 36055860

Group type: EXPERIMENTAL
Intervention: MobileNet deep learning model
Number of subjects: 479